Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Pancreatic Neoplasms

abstract

  • This trial demonstrates improved overall survival with the addition of radiation therapy to GEM in patients with localized unresectable pancreatic cancer, with acceptable toxicity.

publication date

  • November 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3525836

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.34.8904

PubMed ID

  • 21969502

Additional Document Info

start page

  • 4105

end page

  • 12

volume

  • 29

number

  • 31